406 related articles for article (PubMed ID: 16765324)
1. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Celli CM; Tran N; Knox R; Jaiswal AK
Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
[TBL] [Abstract][Full Text] [Related]
3. Role of GRP58 in mitomycin C-induced DNA cross-linking.
Celli CM; Jaiswal AK
Cancer Res; 2003 Sep; 63(18):6016-25. PubMed ID: 14522930
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
[TBL] [Abstract][Full Text] [Related]
5. Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Jamieson D; Tung AT; Knox RJ; Boddy AV
Br J Cancer; 2006 Nov; 95(9):1229-33. PubMed ID: 17031400
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction.
Wang W; Jaiswal AK
Free Radic Biol Med; 2006 Apr; 40(7):1119-30. PubMed ID: 16545679
[TBL] [Abstract][Full Text] [Related]
7. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
8. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
[TBL] [Abstract][Full Text] [Related]
9. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
Walton MI; Smith PJ; Workman P
Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
[TBL] [Abstract][Full Text] [Related]
10. In vivo role of NAD(P)H:quinone oxidoreductase 1 in metabolic activation of mitomycin C and bone marrow cytotoxicity.
Adikesavan AK; Barrios R; Jaiswal AK
Cancer Res; 2007 Sep; 67(17):7966-71. PubMed ID: 17804703
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation.
Dulhanty AM; Li M; Whitmore GF
Cancer Res; 1989 Jan; 49(1):117-22. PubMed ID: 2491748
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
14. A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C.
Joseph P; Jaiswal AK
Br J Cancer; 2000 Apr; 82(7):1305-11. PubMed ID: 10755406
[TBL] [Abstract][Full Text] [Related]
15. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.
Long DJ; Iskander K; Gaikwad A; Arin M; Roop DR; Knox R; Barrios R; Jaiswal AK
J Biol Chem; 2002 Nov; 277(48):46131-9. PubMed ID: 12351651
[TBL] [Abstract][Full Text] [Related]
16. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
Kuehl BL; Buchwald M; Rauth AM
Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941
[TBL] [Abstract][Full Text] [Related]
18. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
Dorr RT; Bowden GT; Alberts DS; Liddil JD
Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
[TBL] [Abstract][Full Text] [Related]
19. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
20. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.
Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA
FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
